Literature DB >> 7199372

Cerebellar hemangioblastomas.

D I Sung, C H Chang, L Harisiadis.   

Abstract

Between 1950 and 1976, 24 patients with cerebellar hemangioblastomas received postoperative radiation therapy. In retrospect, the low-dose radiotherapy that was practiced in the 1950s and early 1960s has been associated with inferior survival rates. Since 1963 and with increased awareness of the effects of radiotherapy, patients receiving high-dose irradiation postoperatively have generally survived longer. Postoperative radiotherapy is used whenever the neoplasm has not been totally excised. This more likely to occur with solid hemangioblastoma and neoplasms arising in the brain stem. In addition, radiotherapy should be used when the tumor recurs after total excision. The recommended dose is in the range of 4500--5000 rads in 4 1/2--5 weeks.

Entities:  

Mesh:

Year:  1982        PMID: 7199372     DOI: 10.1002/1097-0142(19820201)49:3<553::aid-cncr2820490326>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease.

Authors:  Steven A Mills; Michael C Oh; Martin J Rutkowski; Michael E Sughrue; Igor J Barani; Andrew T Parsa
Journal:  Neuro Oncol       Date:  2012-06-21       Impact factor: 12.300

2.  Cerebellar hemangioblastoma presenting as secondary erythrocytosis and aspiration pneumonia.

Authors:  H M Farrukh
Journal:  West J Med       Date:  1996-02

3.  Stereotactic radiosurgery for central nervous system hemangioblastoma: systematic review and meta-analysis.

Authors:  James Pan; Rashad Jabarkheel; Yuhao Huang; Allen Ho; Steven D Chang
Journal:  J Neurooncol       Date:  2017-12-04       Impact factor: 4.130

4.  The long-term outcomes of radiosurgery for intracranial hemangioblastomas.

Authors:  Shunya Hanakita; Tomoyuki Koga; Masahiro Shin; Shunsaku Takayanagi; Akitake Mukasa; Masao Tago; Hiroshi Igaki; Nobuhito Saito
Journal:  Neuro Oncol       Date:  2013-12-12       Impact factor: 12.300

5.  Hemangioblastomatosis of the central nervous system without von Hippel-Lindau disease: a case report.

Authors:  Masayasu Kato; Naoyuki Ohe; Ayumi Okumura; Jun Shinoda; Asuka Nomura; Taro Shuin; Noboru Sakai
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

6.  Linear accelerator stereotactic radiosurgery can modulate the clinical course of Hemangioblastoma: Case series and review of the literature.

Authors:  Z Zibly; Z R Cohen; A Peled; L Zach; U Nissim; Moshe Attia; Christian Graves; K Camphausen; R Spiegelman
Journal:  J Clin Neurosci       Date:  2020-11-11       Impact factor: 1.961

7.  Infratentorial craniospinal irradiation for von Hippel-Lindau: a retrospective study supporting a new treatment for patients with CNS hemangioblastomas.

Authors:  Charles B Simone; Russell R Lonser; John Ondos; Edward H Oldfield; Kevin Camphausen; Nicole L Simone
Journal:  Neuro Oncol       Date:  2011-07-28       Impact factor: 12.300

8.  Long-term follow-up clinical courses of cerebellar hemangioblastoma in von hippel-lindau disease : two case reports and a literature review.

Authors:  Seung Hwan Lee; Bong Jin Park; Tae Sung Kim; Young Jin Lim
Journal:  J Korean Neurosurg Soc       Date:  2010-09-30

9.  Mutations in the von hippel-lindau tumour suppressor gene in central nervous system hemangioblastomas.

Authors:  Cezary Cybulski; Joanna Matyjasik; Marianna Soroka; Janusz Szymaś; Bohdan Górski; Tadeusz Debniak; Anna Jakubowska; Andrzej Bernaczyk; Lech Zimnoch; Grazyna Bierzyńska-Macyszyn; Tomasz Trojanowski; Teresa Wierzba-Bobrowicz; Edmund Prudlak; Alicja Markowska-Wojciechowska; Przemysław Nowacki; Andrzej Roszkiewicz; Radzisław Kordek; Tadeusz Szylberg; Ewa Matyja; Krzysztof Zieliński; Bogdan Woźniewicz; Anna Taraszewska; Wojciech Kozłowski; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2004-03-15       Impact factor: 2.857

10.  Haemangioblastoma of the brain. Computed tomography and angiographic studies in 17 patients.

Authors:  Y Reynier; M Baldini; H Hassoun; R P Vigouroux; J E Paillas
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.